Seasoned HR leader brings over 15 years of experience in global talent strategy, organizational transformation, and workforce planning
MoU aims to strengthen academia-industry collaboration in healthcare research and innovation
Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem
The biotechnology company will tap into Catalent’s expertise in induced pluripotent stem cells and advanced cell-therapy manufacturing
TED?A9 is part of S.Biomedics’ expanding pipeline of stem-cell-based therapies, developed using the company’s proprietary targeted embryonic stem cell differentiation platform
New Jersey-based manufacturing site to support innovative decentralized approach for improved patient experience
The Accelerator will develop products and solutions that will support Sanofi’s mission to transform the practice of medicine with the use of digital, data and artificial intelligence (AI).
Erytech is evaluating valuable strategic options to leverage its Erycaps platform and its development and manufacturing capabilities with complementary assets and/or a broader corporate transaction
This makes the company among few in India to offer fully integrated, end-to-end ADC drug substance development and manufacturing, encompassing payload synthesis, linker development and manufacturing
With this commissioning, Shilpa Medicare joins a very small group of Indian companies capable of offering end-to-end ADC Drug Substance development and manufacturing
Subscribe To Our Newsletter & Stay Updated
